Study

Silexion Granted Approval to Launch Human Trials That Could Redefine the Future of Cancer Treatment

Posted by on | Featured

WSW, NY, 24th March 2026, FinanceWire … Read More

Tags: , , , , , ,

Duke Robotics May Be Emerging as a Hidden Play on AI-Driven Grid Modernization Trends (OTCQB: DUKRD)

Posted by on | Featured

WSW, NY, 24th March 2026, FinanceWire … Read More

Tags: , , , , , , , , , ,

SPAYZ.io Launches P2P Agent Dashboard for High Risk Merchant Payment Operations

Posted by on | Featured

Nicosia, Cyprus, 23rd March 2026, FinanceWire … Read More

Tags: , , , ,

Entera May Be the 1st Winner of FDA’s New Framework Redefining the Multi Billion Dollar Osteoporosis Market

Posted by on | Featured

WSW, NY, 23rd March 2026, FinanceWire … Read More

Tags: , , , , , , , , ,

Palatin’s Case Strengthens as Rhythm’s FDA Approval Validates Hypothalamic Obesity Market (PTN)

Posted by on | Featured

WSW, NY, 20th March 2026, FinanceWire … Read More

Tags: , , , , , , , , ,

Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT)

Posted by on | Featured

WSW, NY, 20th March 2026, FinanceWire … Read More

Tags: , , , , , , , , , ,

Nasus Pharma’s NS002 Demonstrates Consistent Early Advantage in Epinephrine Delivery (NYSE: NSRX)

Posted by on | Featured

WSW, NY, 19th March 2026, FinanceWire … Read More

Tags: , , , , , , , ,

PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention

Posted by on | Featured

WSW, NY, 18th March 2026, FinanceWire … Read More

Tags: , , , , , , ,

Nasus Pharma’s Positive Phase 2 Data Validates the Speed and Reliability of the NS002 Powder Platform

Posted by on | Featured

WSW, NY, 16th March 2026, FinanceWire … Read More

Tags: , , , , , , ,

Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy

Posted by on | Featured

WSW, NY, 12th March 2026, FinanceWire … Read More

Tags: , , , , ,